News

UQ Diamantina Institute researchers have received funding from the National Health and Medical Research Council (NHMRC) across seven projects in the areas of genomic medicine, cancer including melanoma and breast cancer and autoimmune diseases such as rheumatoid arthritis.

The University of Queensland’s efforts to translate research on autoimmune diseases into life-changing treatments has attracted a nomination in the Knowledge Commercialisation Australasia (KCA) Research Commercialisation Awards.

Research institutes at The University of Queensland (UQ) hosted 24 Chinese students from Fudan University and Wenzhou Medical College for six weeks, enabling closer ties between the institutions.

Genetic research will be in the spotlight next week when the most advanced genome sequencing facility in the Southern Hemisphere opens its doors to the public.

Research into blood cancer will be boosted with a new high-level appointment at the University of Queensland Diamantina Institute.

Two UQ Diamantina Institute researchers have been ranked among ‘The world’s most influential scientific minds’ by multinational media body Thomson Reuters.

Researchers at The University of Queensland Diamantina Institute and The University of Sydney Centenary Institute have developed a 3D model of a melanoma tumour that enables them to visualise the growth states of cancer cells in real-time.

Melanoma has a reputation for quickly developing resistance to chemotherapy, but the reason for this has remained unclear.

University of Queensland Diamantina Institute researchers Dr Roberta Mazzieri and Davide Moi have contributed to an important new gene therapy study published in Nature this week.

A vaccine to treat non-Hodgkin’s lymphoma is one step closer after a University of Queensland Diamantina Institute researcher received a grant from the Leukaemia Foundation of Queensland.

The development of novel immune therapies and vaccines in Brisbane and Perth has been awarded an $11.8 million program grant from the National Health and Medical Research Council.

Genotyping is again in the news after the US Food and Drug Administration ordered US genomics company 23andMe to cease conducting genetic testing.

Dr Roberta Mazzieri at the University of Queensland Diamantina Institute is working with cancer researchers in Italy to develop a non-toxic treatment for human breast cancer that delivers an anti-cancer molecule directly to a tumour.

University of Queensland Diamantina Institute researcher Dr Liliana Endo Munoz has discovered that the cells responsible for normal bone destruction may help prevent bone cancer from spreading.

An international study that has identified new genetic regions involved in rheumatoid arthritis has shed light on existing medicines that could be effective in treating the disease.

A strategic partnership between The University of Queensland and global pharmaceutical company LEO Pharma will investigate the genetic causes of squamous cell carcinoma, the world’s second most common skin cancer.

Professor David Evans has been awarded an esteemed Australian Research Council Future Fellowship for his work on the genetic basis of Ankylosing Spondylitis.

Scientists from The University of Queensland’s Diamantina Institute (UQDI) and Institute for Molecular Bioscience (IMB) have identified three new genes behind Jeune Syndrome.